Cytokines Downregulate the Sarcoendoplasmic Reticulum Pump Ca2+ ATPase 2b and Deplete Endoplasmic Reticulum Ca2+, Leading to Induction of Endoplasmic Reticulum Stress in Pancreatic β-Cells
Cytokines Downregulate the Sarcoendoplasmic Reticulum Pump Ca 2+ ATPase 2b and Deplete Endoplasmic Reticulum Ca 2+ , Leading to Induction of Endoplasmic Reticulum Stress in Pancreatic β-Cells Alessandra K. Cardozo 1 , Fernanda Ortis 1 , Joachim Storling 2 , Ying-Mei Feng 1 , Joanne Rasschaert 1 , Mo...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 54; no. 2; pp. 452 - 461 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Alexandria, VA
American Diabetes Association
01.02.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cytokines Downregulate the Sarcoendoplasmic Reticulum Pump Ca 2+ ATPase 2b and Deplete Endoplasmic Reticulum Ca 2+ , Leading to Induction of Endoplasmic Reticulum Stress in Pancreatic β-Cells
Alessandra K. Cardozo 1 ,
Fernanda Ortis 1 ,
Joachim Storling 2 ,
Ying-Mei Feng 1 ,
Joanne Rasschaert 1 ,
Morten Tonnesen 2 ,
Françoise Van Eylen 3 ,
Thomas Mandrup-Poulsen 2 4 ,
André Herchuelz 2 and
Décio L. Eizirik 1
1 Laboratory of Experimental Medicine, Université Libre de Bruxelles, Brussels, Belgium
2 Steno Diabetes Center, Gentofte, Denmark
3 Laboratory of Pharmacology, Université Libre de Bruxelles, Brussels, Belgium
4 Department of Molecular Medicine, Karoliska Institute, Stockholm, Sweden
Address correspondence and reprint requests to Dr. Alessandra K. Cardozo Laboratory of Experimental Medicine, Université Libre
de Bruxelles, Route de Lennik, 808 CP-618, 1070 Brussels, Belgium. E-mail: akupperc{at}ulb.ac.be
Abstract
Cytokines and free radicals are mediators of β-cell death in type 1 diabetes. Under in vitro conditions, interleukin-1β (IL-1β)
+ γ-interferon (IFN-γ) induce nitric oxide (NO) production and apoptosis in rodent and human pancreatic β-cells. We have previously
shown, by microarray analysis of primary β-cells, that IL-1β + IFN-γ decrease expression of the mRNA encoding for the sarcoendoplasmic
reticulum pump Ca 2+ ATPase 2b (SERCA2b) while inducing expression of the endoplasmic reticulum stress–related and proapoptotic gene CHOP (C/EBP
[CCAAT/enhancer binding protein] homologous protein). In the present study we show that cytokine-induced apoptosis and necrosis
in primary rat β-cells and INS-1E cells largely depends on NO production. IL-1β + IFN-γ, via NO synthesis, markedly decreased
SERCA2b protein expression and depleted ER Ca 2+ stores. Of note, β-cells showed marked sensitivity to apoptosis induced by SERCA blockers, as compared with fibroblasts.
Cytokine-induced ER Ca 2+ depletion was paralleled by an NO-dependent induction of CHOP protein and activation of diverse components of the ER stress
response, including activation of inositol-requiring ER-to-nucleus signal kinase 1α (IRE1α) and PRK (RNA-dependent protein
kinase)-like ER kinase (PERK)/activating transcription factor 4 (ATF4), but not ATF6. In contrast, the ER stress–inducing
agent thapsigargin triggered these four pathways in parallel. In conclusion, our results suggest that the IL-1β + IFN-γ–induced
decrease in SERCA2b expression, with subsequent depletion of ER Ca 2+ and activation of the ER stress pathway, is a potential contributory mechanism to β-cell death.
ATF, activating transcription factor
BiP, immunoglobulin heavy-chain binding protein
[Ca2+]i, intracellular Ca2+ concentration
CHOP, C/EBP (CCAAT/enhancer binding protein) homologous protein
CPA, cyclopiazonic acid
eIF2α, eukaryotic translation initiation factor 2α
ER, endoplasmic reticulum
FACS, fluorescence-activated cell sorting
GAPDH, glyceraldehyde-3-phosphate dehydrogenase
IFN-γ, γ-interferon
IL, interleukin
iNOS, inducible nitric oxide synthase
IRE1α, inositol-requiring ER-to-nucleus signal kinase 1α
JNK, c-Jun NH2-terminal kinase
LMA, NG-methyl-l-arginine
PERK, PRK (RNA-dependent protein kinase)-like ER kinase
SERCA, sarcoendoplasmic reticulum Ca2+ ATPase
xbp-1, X-box binding protein-1
Footnotes
T.M.-P. is employed by, holds stock in, and has received grant/research support from Novo Nordisk.
Accepted October 19, 2004.
Received April 7, 2004.
DIABETES |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0012-1797 1939-327X |
DOI: | 10.2337/diabetes.54.2.452 |